Integrin and Regulatory Foxp3 T Cells Constitute Two Functionally Distinct Human CD4 T Cell Subsets Oppositely Modulated by TNF Blockade

[1]  J. Bluestone,et al.  Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potential. , 2006, Seminars in immunology.

[2]  S. Rosenberg,et al.  IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. , 2006, Blood.

[3]  S. Kim-Schulze,et al.  Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Edward Y. Kim,et al.  TNF Receptor Type 2 (p75) Functions as a Costimulator for Antigen-Driven T Cell Responses In Vivo1 , 2006, The Journal of Immunology.

[5]  J. Bluestone,et al.  How do CD4+CD25+ regulatory T cells control autoimmunity? , 2005, Current opinion in immunology.

[6]  J. Lohr,et al.  Sequential development of interleukin 2–dependent effector and regulatory T cells in response to endogenous systemic antigen , 2005, The Journal of experimental medicine.

[7]  D. Valmori,et al.  A peripheral circulating compartment of natural naive CD4 Tregs. , 2005, The Journal of clinical investigation.

[8]  F. Sallusto,et al.  Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia , 2005, The Journal of experimental medicine.

[9]  S. Lira,et al.  Lymph Node Occupancy Is Required for the Peripheral Development of Alloantigen-Specific Foxp3+ Regulatory T Cells1 , 2005, The Journal of Immunology.

[10]  S. Sakaguchi.  Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self , 2005, Nature Immunology.

[11]  M. Colombo,et al.  Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. , 2005, Blood.

[12]  A. Rudensky,et al.  A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 , 2005, Nature Immunology.

[13]  S. Ben-Horin,et al.  The role of very late antigen-1 in immune-mediated inflammation. , 2004, Clinical immunology.

[14]  Edward Y. Kim,et al.  Critical Role of TNF Receptor Type-2 (p75) as a Costimulator for IL-2 Induction and T Cell Survival: A Functional Link to CD281 , 2004, The Journal of Immunology.

[15]  D. Isenberg,et al.  Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy , 2004, The Journal of experimental medicine.

[16]  E. Shevach,et al.  Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. , 2004, Seminars in immunology.

[17]  P. Doherty,et al.  The Collagen Binding α1β1 Integrin VLA-1 Regulates CD8 T Cell-Mediated Immune Protection against Heterologous Influenza Infection , 2004 .

[18]  L. Chess,et al.  Expression of the α1β1 integrin, VLA-1, marks a distinct subset of human CD4+ memory T cells , 2003 .

[19]  S. Ziegler,et al.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. , 2003, The Journal of clinical investigation.

[20]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[21]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[22]  H. Mcdevitt,et al.  Tumor necrosis factor-α regulation of CD4+C25+ T cell levels in NOD mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Fathman,et al.  The Subpopulation of CD4+CD25+ Splenocytes That Delays Adoptive Transfer of Diabetes Expresses L-Selectin and High Levels of CCR71 , 2002, The Journal of Immunology.

[24]  Michael Karin,et al.  NF-κB at the crossroads of life and death , 2002, Nature Immunology.

[25]  J. Shimizu,et al.  Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance , 2002, Nature Immunology.

[26]  V. Koteliansky,et al.  Regulation of inflammation by collagen-binding integrins α1β1 and α2β1 in models of hypersensitivity and arthritis , 2000 .

[27]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[28]  Ethan M. Shevach,et al.  CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production , 1998, The Journal of experimental medicine.

[29]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[30]  L. Chess,et al.  A novel monoclonal antibody, 1B3.1, binds to a new epitope of the VLA-1 molecule. , 1989, Cellular immunology.

[31]  D. Glass,et al.  Very late activation antigens on rheumatoid synovial fluid T lymphocytes. Association with stages of T cell activation. , 1986, The Journal of clinical investigation.

[32]  M. Ehrenfeld,et al.  Expression and functions of very late antigen 1 in inflammatory joint diseases , 2004, Journal of Clinical Immunology.

[33]  M. Feldmann,et al.  Cytokine blockade in rheumatoid arthritis. , 2001, Advances in experimental medicine and biology.

[34]  V. Koteliansky,et al.  Anti-Very Late Antigen-1 Monoclonal Antibody Modulates the Development of Secondary Lesion and T-Cell Response in Experimental Arthritis , 2000, Laboratory Investigation.

[35]  J. Strominger,et al.  VLA‐1: a T cell surface antigen which defines a novel late stage of human T cell activation , 1985, European journal of immunology.